Spenceria

Spenceria is a plant with no traditional uses recorded. Scientific evidence suggests that its polyphenols, particularly proanthocyanidins, may exhibit significant anti-asthmatic activities in rats by reducing inflammatory cell counts and cytokines, alleviating lung damage, and downregulating the PI3K/Akt signaling pathway. Additionally, extracts from Spenceria ramalana have shown varying degrees of inhibition against advanced glycation end product formation and reduced high glucose-induced hyaloid-retinal vessel dilation in zebrafish. These findings highlight its potential in managing asthma through modulation of key signaling pathways, though further research is needed for chemical standardization. No major safety issues or drug interactions have been recorded, but these areas require further investigation to confirm the plant's full safety profile and interactions with other medications.

仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。